Schroder Investment Management Group
RYTM icon

Schroder Investment Management Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Schroder Investment Management Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7M Buy
160,518
+28,844
+22% +$2.61M 0.01% 562
2026
Q1 		$10.2M Buy
+131,674
New +$12.8M 0.01% 657
2025
Q4 		– Sell
-18,042
Closed -$1.82M – 1205
2025
Q3 		$1.82M Buy
18,042
+424
+2% +$39.4K ﹤0.01% 947
2025
Q2 		$1.11M Hold
17,618
– – ﹤0.01% 984
2025
Q1 		$965K Buy
+17,618
New +$977K ﹤0.01% 991

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Schroder Investment Management Group's RYTM Position: Q2 2026 in Review

Schroder Investment Management Group increased its Rhythm Pharmaceuticals (RYTM) stake by 22% in Q2 2026, buying an estimated $2.61M and bringing the position to 160,518 shares worth $17.7M. The position accounts for 0.01% of the portfolio, ranked #562.

Schroder Investment Management Group first reported a position in RYTM in Q1 2025 and has held it in 5 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Schroder Investment Management Group held 160,518 shares of Rhythm Pharmaceuticals worth $17.7M as of Q2 2026.
  • Schroder Investment Management Group bought 28,844 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $2.61M.
  • Rhythm Pharmaceuticals made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #562 holding.
  • Schroder Investment Management Group first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.